Select Medical HoldingsFRA:S24 +1.41%77 EBITDA Margin % is 10.42% as of Mar. 2026, which is 12% below its 10-year median of 11.81. GuruFocus rates FRA:S24 with a GF Score™ of 77/100 and a GF Value™ of €14.99. The stock has 7 warning signs investors should review. Among 666 Healthcare Providers & Services companies, Select Medical Holdings ranks worse than 52.55% on this metric.
Select Medical Holdings (FRA:S24) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Select Medical Holdings EBITDA Margin % Related Terms
Select Medical Holdings EBITDA Margin % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:S24 vs SGRY, MD, AGL: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Select Medical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Select Medical Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Select Medical Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Select Medical Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Select Medical Holdings (FRA:S24) has a EBITDA Margin % of 10.42% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Select Medical Holdings and its competitors. This is 12% below median its historical median of 11.81. Over the past decade, Select Medical Holdings' EBITDA Margin % has ranged from 8.21 to 15.61. According to the industry distribution chart, Select Medical Holdings ranks #350 out of 666 companies in the Healthcare Providers & Services industry, placing it in the top 52.6%.
Is Select Medical Holdings' EBITDA Margin % too high?
Select Medical Holdings' current EBITDA Margin % of 10.42% is 12% below median its 10-year median of 11.81. Over the past 10 years, this metric has ranged from a low of 8.21 to a high of 15.61. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Select Medical Holdings' value of 10.42% is 1.8% above this industry median. Based on the distribution chart, Select Medical Holdings ranks #350 out of 666 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Select Medical Holdings has a GF Score™ of 77/100, reflecting its overall financial health beyond just this single metric.
How does Select Medical Holdings' EBITDA Margin % compare to SGRY and MD?
According to the Healthcare Providers & Services industry distribution chart, Select Medical Holdings ranks #350 out of 666 companies for EBITDA Margin %. This places Select Medical Holdings in the lower half of its industry. The industry median EBITDA Margin % is 10.24. Select Medical Holdings' value of 10.42% is 1.8% above this benchmark. Historically, Select Medical Holdings' own EBITDA Margin % has ranged from 8.21 to 15.61 over the past decade. While the company's 10-year median is 11.81 vs. the industry median of 10.24, Select Medical Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 666 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Select Medical Holdings's current EBITDA Margin % of 10.42% is 1.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Select Medical Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Select Medical Holdings's current EBITDA Margin % is 10.42%, which is 12% below median its own 10-year median of 11.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Select Medical Holdings stock overvalued right now?
Select Medical Holdings (FRA:S24) has a current EBITDA Margin % of 10.42%. The stock's GF Value™ is €14.99, compared to a current price of €14.40 — trading 3.9% below its estimated fair value. The current EBITDA Margin % is 10.42%, which is 12% below median its 10-year median of 11.81 and 1.8% above the Healthcare Providers & Services industry median of 10.24. Select Medical Holdings' overall GF Score™ is 77/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Select Medical Holdings (FRA:S24), the current EBITDA Margin % is 10.42% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Select Medical Holdings (FRA:S24) Overvalued in 2026?
Based on GuruFocus' analysis, Select Medical Holdings stock appears to be undervalued.
The current stock price of €14.40 is trading 3.9% below its estimated GF Value™ of €14.99.
Key valuation signals for FRA:S24:
EBITDA Margin %: 10.42% (12% below median its 10-year median of 11.81)
GF Value™: €14.99 vs. price of €14.40 (3.9% below fair value)
Industry Position: 1.8% above the Healthcare Providers & Services median (#350 of 666)
No single metric tells the full story. See the FRA:S24 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Select Medical Holdings Corp is a healthcare company that operates through three segments: critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics. Critical illness recovery hospitals which derives maximum revenue consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. The rehabilitation hospital segment consists of hospitals designed to serve patients that require intensive physical rehabilitation care. Patients are typically admitted to critical illness recovery hospitals and rehabilitation hospitals from general acute care hospitals. The outpatient rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services.
77GF Score
Get the complete analysis for FRA:S24
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:S24 has been successfully added to your 
